Navigation Links
Drug Controller General to Withdraw Drug that Affects Vulture Population

Concerned at the effect of the anti-inflammatory drug Dicolofenec on the country's vulture population, the Drug Controller General has decided to withdraw licences for manufacturing it for veterinary use //.

At a press meet here today, the director of the prominent NGO Bombay Natural History Society (BNHS), Asad R Rahmani, presented a copy of Drug Controller General Ashwini Kumar's May 11 circular to all state drugs controllers to this effect.

The circular said with the approval of the Health Mministry, the licences granted for making Diclofenec for veterinary use should be withdrawn and the marketing of such formulations phased out within a period of three months.

Stating that serious concern had been expressed over the decline of the vulture population, the circular said extensive studies had indicated the use of Diclofenec among livestock was a major cause for this.

Expressing concern at the fall in the vulture population, Rahmani said his organisation had been urging the Centre to ban the drug for veterinary use.

Vultures are exposed to Diclofenec when they eat the carcasses of livestock treated with the drug before death, resulting in poisoning of the birds and their death because of kidney failure, the circular said.

It was, therefore, felt Diclofenec for veterinary use should be phased out and alternate safer and effective drugs like Meloxicam should be used for treating animals in veterinary healthcare.

This will help in saving the vulture population and the ecological balance in the animal world, Kumar said.


'"/>




Page: 1

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. General Practitioners are earning mighty amount?
5. Former IMO President Shows Interest In Winning General Election
6. Severe Paucity of General Practitioners in Australia
7. WHO Director-General passes away on 23rd of May
8. IT for General Practitioners
9. Fewer Graduates Choosing General Practice
10. Stroke Rehab Programs Should Be Generalized
11. China Nominates Margaret Chan to Run for WHO Director-Generals Post
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... ... and Android devices. VisualDx is the first point of care diagnostic support ... general medicine. The system speeds diagnosis, therapy decisions and patient education for ...
(Date:5/5/2016)... ... ... is just around the corner. Summer means a lot of different things to people. ... all day and night. Parents often lament the coming of summer as they will have ... trips to the beach, backyard cookouts, fireworks on the Fourth of July, and even perhaps ...
(Date:5/5/2016)... ... , ... Dermatologic surgeons performed nearly 10 million medically necessary and cosmetic procedures ... , The results of the 2015 ASDS Survey on Dermatologic Procedures released today reveal ... the growing popularity of soft-tissue fillers and body sculpting procedures. , For the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... , The Medical Society of Northern Virginia, Announces DoctorsTelemed?, A telehealth ... Medical Society of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution that ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Nepenthe Laboratory Services ... Elementary School last week to raise non-perishable food item donations for Food for Lane ... Day” hosted on NBC. , “The goal of the assembly was to create an ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016  It,s time for an upgrade. There are many medical recorders ... 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix ... a world class manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
Breaking Medicine Technology: